Technical Analysis for 0ABW - Egetis Therapeutics AB
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| BB Squeeze Ended | Range Expansion | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | -6.75% | |
| Calm After Storm | Range Contraction | -6.75% | |
| Narrow Range Bar | Range Contraction | -6.75% | |
| Stochastic Reached Oversold | Weakness | -6.75% | |
| Gapped Up | Strength | -6.75% | |
| Oversold Stochastic | Weakness | -6.75% | |
| Bollinger Band Squeeze | Range Contraction | -1.66% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Egetis Therapeutics AB (publ), a pharmaceutical drug development company, focuses on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment. Its products pipeline includes Aladote, a drug to reduce the risk of acute liver injury associated with acetaminophen/paracetamol poisoning, which is in phase IIb/III clinical trial; and Emcitate, a drug for the treatment of MCT8 deficiency, a rare inborn error of thyroid hormone signaling that is in phase IIb/III clinical trial. The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics AB (publ) was incorporated in 2006 and is based in Stockholm, Sweden.
Keywords: Drug Development Analgesics Paracetamol
Classification
Keywords: Drug Development Analgesics Paracetamol
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.18 |
| 52 Week Low | 3.855 |
| Average Volume | 4,457 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 5.78 |
| 20-Day Moving Average | 6.50 |
| 10-Day Moving Average | 6.52 |
| Average True Range | 0.26 |
| RSI (14) | 41.86 |
| ADX | 21.04 |
| +DI | 39.94 |
| -DI | 51.91 |
| Chandelier Exit (Long, 3 ATRs) | 6.31 |
| Chandelier Exit (Short, 3 ATRs) | 6.66 |
| Upper Bollinger Bands | 7.13 |
| Lower Bollinger Band | 5.88 |
| Percent B (%b) | 0.05 |
| BandWidth | 19.26 |
| MACD Line | 0.12 |
| MACD Signal Line | 0.24 |
| MACD Histogram | -0.1249 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.94 | ||||
| Resistance 3 (R3) | 5.94 | 5.94 | 5.94 | ||
| Resistance 2 (R2) | 5.94 | 5.94 | 5.94 | 5.94 | |
| Resistance 1 (R1) | 5.94 | 5.94 | 5.94 | 5.94 | 5.94 |
| Pivot Point | 5.94 | 5.94 | 5.94 | 5.94 | 5.94 |
| Support 1 (S1) | 5.94 | 5.94 | 5.94 | 5.94 | 5.94 |
| Support 2 (S2) | 5.94 | 5.94 | 5.94 | 5.94 | |
| Support 3 (S3) | 5.94 | 5.94 | 5.94 | ||
| Support 4 (S4) | 5.94 |
